How long does the effect of Fruquintinib last?

The duration of effect of Fruquintinib (Fruquintinib) varies depending on individual patient differences, disease characteristics, and treatment options. The duration of a drug's effect is usually assessed through clinical observation and scientific research, especially in relevant clinical trials.

In some clinical trials, fruquintinib has shown some anti-tumor activity in patients with advanced colorectal and gastric cancer. However, there are several factors to consider when it comes to how long a drug's effect lasts:

1.The speed of disease progression: The growth rate of tumors and the degree of disease progression are different in different patients. Therefore, the duration of fruquintinib's efficacy may be affected by the biology of the disease.

2.Treatment response: The patient's treatment response to fruquintinib will also affect the duration of the drug's effect. Some patients may show a longer period of stable disease in response to the drug, while others may experience disease progression after a period of time.

3.Drug tolerance: During the use of fruquintinib, some patients may develop drug tolerance, that is, the drug's therapeutic effect on tumors gradually weakens. This may lead to loss of efficacy and progression of the disease.

4.Treatment plan: The treatment plan used by patients to receive fruquintinib will also affect the duration of the drug's effect. Some patients may require long-term maintenance therapy, while others may complete the treatment regimen in the short term.

Overall, the goal of fruquintinib as a maintenance treatment drug is to delay tumor growth, increase patient survival time, and improve quality of life. However, the specific duration of drug effect needs to be comprehensively evaluated based on the patient's individual situation and treatment response. When formulating a treatment plan, doctors usually regularly monitor the patient's condition and the efficacy of the drug, and adjust the treatment plan in a timely manner to improve the effectiveness of the treatment. During the medication period, patients should closely cooperate with the doctor's advice and conduct regular follow-up and examinations to ensure the best therapeutic effect.

Fruquintinib is a drug developed in Hong Kong, China. It has been approved for marketing by the State Food and Drug Administration and has been included in medical insurance. Patients can buy it in domestic hospital pharmacies at a price of about one to two thousand. For specific prices, please consult the local hospital pharmacy.